Trans-resveratrol is a polyphenol found naturally in grape skins, peanuts, and some berries. It is popular in healthy aging circles because it has been studied for metabolic resilience, mitochondrial function, and cardiovascular markers. We use the trans form because it is the dominant form found in nature and the one most commonly used in human research. (PMC)
Why we use 150 mg in ResilienZ-12
ResilienZ-12 includes 150 mg of trans-resveratrol per day because that dose hits a rare sweet spot: it has real human clinical data behind it and it sits within established safety guidance.
In a randomized, double-blind, placebo-controlled crossover study in 11 obese men, 150 mg/day for 30 days produced a cluster of favorable metabolic changes. Researchers reported improvements in muscle mitochondrial respiration on a fatty acid-derived substrate, decreases in intrahepatic (liver) lipid content, reductions in circulating glucose and triglycerides, a drop in systolic blood pressure, and improvement in HOMA index (a marker related to insulin resistance). (PubMed)
On the safety side, the European Food Safety Authority reviewed the evidence for synthetic trans-resveratrol as a novel food ingredient and concluded that an intended intake level of 150 mg/day for adults does not raise safety concerns. (Prod Storage Hoeringspo)
What the research suggests it supports
Metabolic flexibility and cellular energy
Healthy aging is not about “more willpower.” It is about how well your cells handle fuel, stress, and recovery. In that same 150 mg/day human trial, resveratrol activated pathways tied to energy regulation in muscle and improved measures tied to metabolic health, which is why resveratrol is often described as supporting a more resilient metabolic profile in certain populations. (PubMed)
Heart and circulation support (modest, meaningful direction)
Across randomized trials, resveratrol’s blood-pressure effects tend to be modest overall, with meta-analyses suggesting a stronger impact on systolic blood pressure at higher doses. (PubMed) Still, it is notable that the 150 mg/day trial reported a drop in systolic blood pressure after 30 days. (PubMed)
Glucose and insulin support (stronger signal when it is needed most)
Meta-analyses consistently suggest that benefits on fasting glucose, insulin, and insulin resistance are more likely in people with type 2 diabetes or impaired glucose control, while results in metabolically healthy groups are mixed. (PMC)
That “context matters” pattern is exactly why 150 mg/day is compelling as a daily-support dose: it is enough to be studied seriously, without trying to turn a supplement into a medication. (PubMed)
Why “trans-resveratrol” specifically
Resveratrol exists in trans and cis forms. The trans form is the dominant naturally occurring isomer and is widely used in research. It can isomerize under certain conditions (like UV exposure), which is one reason supplement labeling often specifies “trans-resveratrol.” (PMC)
Bottom line
Trans-resveratrol is not hype in a capsule. At 150 mg/day, it has human clinical evidence showing favorable shifts in multiple metabolic and cardiovascular-related markers in an at-risk group, plus a clear safety green light from EFSA for adult use at that intake level. (PubMed) That is exactly why it belongs in a daily healthy-aging formula like ResilienZ-12: steady, research-backed support that fits real life.
Supplements support health but aren’t intended to diagnose, treat, cure, or prevent disease. If you’re pregnant, nursing, taking medications, or have a medical condition, talk with your healthcare professional.
